Literature DB >> 18381785

Subclinical atherosclerosis in psoriatic arthritis: a case-control study.

Lihi Eder1, Devy Zisman, Menashe Barzilai, Arie Laor, Michal Rahat, Michael Rozenbaum, Haim Bitterman, Joy Feld, Doron Rimar, Itzhak Rosner.   

Abstract

OBJECTIVE: To investigate the prevalence of subclinical atherosclerosis among patients with psoriatic arthritis (PsA).
METHODS: Forty patients with PsA were enrolled. Controls were matched by age, sex, and atherosclerotic risk factors. All patients and controls underwent duplex scan of the carotid arteries. Carotid intima-media thickness (IMT) was evaluated and the presence of atherosclerotic plaques was recorded. The plaques were graded and carotid plaque index was calculated.
RESULTS: Patients with PsA had a higher IMT (mean +/- standard deviation, 1.04 +/- 0.35 mm vs 0.88 +/- 0.29 mm in controls; p = 0.03), and had a higher carotid plaque index than did matched controls (2.3 +/- 2.6, compared to 1.12 +/- 2.09; p = 0.03). Multivariate analysis demonstrated that PsA status as well as age and triglyceride levels were associated with the presence of carotid plaque. Other traditional risk factors were more prevalent among patients with PsA; however, they were not statistically significant.
CONCLUSION: Our study demonstrates that patients with PsA may have an increased prevalence of subclinical atherosclerosis. These findings may not be solely attributable to traditional risk factors alone. Special attention and strict control of atherosclerotic risk factors in patients with PsA is warranted.

Entities:  

Mesh:

Year:  2008        PMID: 18381785

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  31 in total

1.  Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.

Authors:  Baris Yilmazer; Tayfun Sahin; Berrin Öztaş Unlu; Hale Maral Kir; Ayse Cefle
Journal:  Rheumatol Int       Date:  2015-02-11       Impact factor: 2.631

Review 2.  Cardiometabolic Disorders in Psoriatic Disease.

Authors:  Curtis Sobchak; Lihi Eder
Journal:  Curr Rheumatol Rep       Date:  2017-08-26       Impact factor: 4.592

3.  Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel.

Authors:  Devy Zisman; Lihi Eder; Muna Elias; Arie Laor; Haim Bitterman; Michael Rozenbaum; Joy Feld; Doron Rimar; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

4.  High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound.

Authors:  Rosario Ibáñez-Bosch; Juliana Restrepo-Velez; Miguel Medina-Malone; Laura Garrido-Courel; Inmaculada Paniagua-Zudaire; Eduardo Loza-Cortina
Journal:  Rheumatol Int       Date:  2016-11-24       Impact factor: 2.631

5.  Carotid intima-media thickness and serum leptin in psoriasis.

Authors:  B Enany; A K El Zohiery; R Elhilaly; T Badr
Journal:  Herz       Date:  2011-12-01       Impact factor: 1.443

6.  Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients.

Authors:  Raghda Ghonimy Elsheikh; Tarek El-Sayed Amin; Amal Ahmad El-Ashmawy; Samah Ibrahim Abd El-Fttah Abdalla
Journal:  J Saudi Heart Assoc       Date:  2013-12-18

Review 7.  The perspective on psoriatic arthritis in Asia.

Authors:  Ying-Ying Leung; Lai-Shan Tam; Edmund K Li
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

8.  Atherosclerosis in Psoriatic Arthritis: A Multiparametric Analysis Using Imaging Technique and Laboratory Markers of Inflammation and Vascular Function.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Int J Angiol       Date:  2016-07-01

Review 9.  Endothelial progenitor cell dysfunction in rheumatic disease.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

10.  Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease.

Authors:  Alessandro Giollo; Andrea Dalbeni; Giovanni Cioffi; Federica Ognibeni; Davide Gatti; Luca Idolazzi; Giovanni Orsolini; Pietro Minuz; Maurizio Rossini; Cristiano Fava; Ombretta Viapiana
Journal:  Clin Rheumatol       Date:  2017-09-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.